These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 32026868)

  • 21. Within-patient variability in clinical presentation of gamma-hydroxybutyrate withdrawal: a case report.
    Glasper A; McDonough M; Bearn J
    Eur Addict Res; 2005; 11(3):152-4. PubMed ID: 15990433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial.
    Lingford-Hughes A; Patel Y; Bowden-Jones O; Crawford MJ; Dargan PI; Gordon F; Parrott S; Weaver T; Wood DM
    Trials; 2016 Sep; 17(1):472. PubMed ID: 27677382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing alcohol versus baclofen withdrawal syndrome in patients treated with baclofen for alcohol use disorder.
    Rolland B; Jaillette E; Carton L; Bence C; Deheul S; Saulnier F; Bordet R; Cottencin O
    J Clin Psychopharmacol; 2014 Feb; 34(1):153-6. PubMed ID: 24346755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies.
    Leo RJ; Baer D
    Psychosomatics; 2005; 46(6):503-7. PubMed ID: 16288128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
    Koek W; Carter LP; Wu H; Coop A; France CP
    Behav Pharmacol; 2006 May; 17(3):239-47. PubMed ID: 16572002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gamma-hydroxy butyrate withdrawal delirium: a case report.
    Miglani JS; Kim KY; Chahil R
    Gen Hosp Psychiatry; 2000; 22(3):213-5. PubMed ID: 11012302
    [No Abstract]   [Full Text] [Related]  

  • 29. Diazepam in the treatment of GHB dependence.
    Addolorato G; Caputo F; Capristo E; Gasbarrini G
    Br J Psychiatry; 2001 Feb; 178():183. PubMed ID: 11157447
    [No Abstract]   [Full Text] [Related]  

  • 30. Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.
    von Theobald L; Rousselet M; Cholet J; Debar H; Boels D; Victorri-Vigneau C; Grall-Bronnec M
    J Addict Med; 2017; 11(3):231-234. PubMed ID: 28125446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GHB-induced delirium: a case report and review of the literature of gamma hydroxybutyric acid.
    Hernandez M; McDaniel CH; Costanza CD; Hernandez OJ
    Am J Drug Alcohol Abuse; 1998 Feb; 24(1):179-83. PubMed ID: 9513637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of severe, treatment resistant GHB withdrawal through thiopental-coma.
    Vos CF; Pop-Purceleanu M; van den Berg MJW; Schellekens AFA
    Subst Abus; 2021; 42(1):33-38. PubMed ID: 33044905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma-hydroxybutyric acid tolerance and withdrawal in a rat model.
    Bania TC; Ashar T; Press G; Carey PM
    Acad Emerg Med; 2003 Jul; 10(7):697-704. PubMed ID: 12837642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
    Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
    Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic baclofen abuse and withdrawal delirium.
    Nasti JJ; Brakoulias V
    Aust N Z J Psychiatry; 2011 Jan; 45(1):86-7. PubMed ID: 21058925
    [No Abstract]   [Full Text] [Related]  

  • 36. Gamma hydroxybutyric acid (GHB) intoxication.
    Mason PE; Kerns WP
    Acad Emerg Med; 2002 Jul; 9(7):730-9. PubMed ID: 12093716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
    Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature.
    Karol DE; Muzyk AJ; Preud'homme XA
    Gen Hosp Psychiatry; 2011; 33(1):84.e1-2. PubMed ID: 21353141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological Treatment in γ-Hydroxybutyrate (GHB) and γ-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention.
    Kamal RM; van Noorden MS; Wannet W; Beurmanjer H; Dijkstra BA; Schellekens A
    CNS Drugs; 2017 Jan; 31(1):51-64. PubMed ID: 28004314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detoxification of patients with GHB dependence].
    de Weert-van Oene GH; Schellekens AF; Dijkstra BA; Kamal R; de Jong CA
    Tijdschr Psychiatr; 2013; 55(11):885-90. PubMed ID: 24242149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.